Lista de obras - Meghna Jani - Dominio Público Uruguay

'Twitterland': a brave new world?

artículo científico publicado en 2017

A microcosting study of immunogenicity and tumour necrosis factor alpha inhibitor drug level tests for therapeutic drug monitoring in clinical practice

scientific article published on 29 August 2016

Abatacept in the long-term treatment of rheumatoid arthritis ⬇️

artículo científico publicado el 1 de marzo de 2012

Annual increase in body mass index in children with asthma on higher doses of inhaled steroids.

artículo científico publicado en 2005

Association of Pharmacological Biomarkers with Treatment Response and Longterm Disability in Patients with Psoriatic Arthritis: Results from OUTPASS

artículo científico publicado en 2019

Building the future of rheumatology: the role of national and international networks

artículo científico publicado en 2017

Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritis

artículo científico publicado en 2015

Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritis.

artículo científico publicado en 2015

Cryptococcal meningitis in an HIV-negative patient with rheumatoid arthritis treated with rituximab

artículo científico publicado en 2011

Detection of anti-drug antibodies using a bridging ELISA compared with radioimmunoassay in adalimumab-treated rheumatoid arthritis patients with random drug levels. ⬇️

scientific article published on 25 August 2016

Drug safety and immunogenicity of tumour necrosis factor inhibitors: the story so far.

artículo científico publicado en 2018

Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA. ⬇️

artículo científico publicado en 2017

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update ⬇️

artículo científico publicado en 2017

Effectiveness of switching between biologics in psoriatic arthritis- results of a large regional survey

artículo científico publicado en 2014

Frequent discussion of insomnia and weight gain with glucocorticoid therapy: an analysis of Twitter posts

article

Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies.

artículo científico publicado en 2014

Glucocorticoid use is associated with an increased risk of hypertension

artículo científico publicado en 2020

High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort ⬇️

artículo científico publicado en 2016

Impact of Adverse Events Associated With Medications in the Treatment and Prevention of Rheumatoid Arthritis

scientific article published on 10 June 2019

Latent class trajectory modelling of 2-components-DAS28 identifies multiple rheumatoid arthritis phenotypes of response to biologic disease modifying anti-rheumatic drugs

artículo científico publicado en 2020

Opioids are not just an American problem.

artículo científico publicado en 2017

Pharmacogenetics of treatment response in psoriatic arthritis

artículo científico publicado en 2015

Practical Management of Respiratory Comorbidities in Patients with Rheumatoid Arthritis.

artículo científico

Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?

artículo científico publicado en 2019

Primary percutaneous coronary intervention for acute ST elevation myocardial infarction--first year's experience of a tertiary referral centre in the UK.

artículo científico publicado en 2008

Social media use among young rheumatologists and basic scientists: results of an international survey by the Emerging EULAR Network (EMEUNET).

artículo científico publicado en 2016

The Genetics of Psoriasis and Psoriatic Arthritis

artículo científico publicado en 2019

The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases.

artículo científico

The safety of biologic therapies in RA-associated interstitial lung disease

artículo científico

Therapeutic monitoring of TNF inhibitors for rheumatoid arthritis: evidence required following NICE's recommendations

scientific article published on 22 June 2020

Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study

artículo científico publicado en 2020

Translating research into clinical practice: quality improvement to halve non-adherence to methotrexate

artículo científico publicado en 2020

Unilateral breast oedema in a case of non-rheumatic giant left atrium.

artículo científico publicado en 2009

Lista de obras de Meghna Jani

'Twitterland': a brave new world?

A microcosting study of immunogenicity and tumour necrosis factor alpha inhibitor drug level tests for therapeutic drug monitoring in clinical practice

Abatacept in the long-term treatment of rheumatoid arthritis ⬇️

Annual increase in body mass index in children with asthma on higher doses of inhaled steroids.

Association of Pharmacological Biomarkers with Treatment Response and Longterm Disability in Patients with Psoriatic Arthritis: Results from OUTPASS

Building the future of rheumatology: the role of national and international networks

Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritis

Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritis.

Cryptococcal meningitis in an HIV-negative patient with rheumatoid arthritis treated with rituximab

Detection of anti-drug antibodies using a bridging ELISA compared with radioimmunoassay in adalimumab-treated rheumatoid arthritis patients with random drug levels. ⬇️

Drug safety and immunogenicity of tumour necrosis factor inhibitors: the story so far.

Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA. ⬇️

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update ⬇️

Effectiveness of switching between biologics in psoriatic arthritis- results of a large regional survey

Frequent discussion of insomnia and weight gain with glucocorticoid therapy: an analysis of Twitter posts

Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies.

Glucocorticoid use is associated with an increased risk of hypertension

High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort ⬇️

Impact of Adverse Events Associated With Medications in the Treatment and Prevention of Rheumatoid Arthritis

Latent class trajectory modelling of 2-components-DAS28 identifies multiple rheumatoid arthritis phenotypes of response to biologic disease modifying anti-rheumatic drugs

Opioids are not just an American problem.

Pharmacogenetics of treatment response in psoriatic arthritis

Practical Management of Respiratory Comorbidities in Patients with Rheumatoid Arthritis.

Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?

Primary percutaneous coronary intervention for acute ST elevation myocardial infarction--first year's experience of a tertiary referral centre in the UK.

Social media use among young rheumatologists and basic scientists: results of an international survey by the Emerging EULAR Network (EMEUNET).

The Genetics of Psoriasis and Psoriatic Arthritis

The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases.

The safety of biologic therapies in RA-associated interstitial lung disease

Therapeutic monitoring of TNF inhibitors for rheumatoid arthritis: evidence required following NICE's recommendations

Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study

Translating research into clinical practice: quality improvement to halve non-adherence to methotrexate

Unilateral breast oedema in a case of non-rheumatic giant left atrium.